ZURA:NASDAQ, Zura Bio Limited

ZURA stock overview

Zura Bio Limited (ZURA:NASDAQ) closed at $4.25 on October 15, 2026, down 3.74% on the day. The stock trades 42.9% below its 52-week high of $7.44 and 34.8% above its 52-week low of $3.15. Over the past year, it gained 18.9%. Zura Bio Limited is part of the Health Care sector.

Key figures

Price: $4.25
Day change: -3.74%
Volume: 3,133,188
Average volume: 1,898,571
Market cap: 406M+
52-week range: $3.15 – $7.44
50-day average: $5.09
200-day average: $5.31

Performance

5D	1M	3M	6M	1Y
+10.25%	-10.55%	-19.08%	-17.88%	+18.87%

Price action over the past year

In 252 trading sessions since October 14, 2025, ZURA closed higher on 130 days (52%). Its best day was January 21, 2026 (+26.15%) and its worst was July 1, 2026 (-15.17%). The stock moved 10% or more in a single session 10 times.

Recent signals

Oct 14, 2026: Trading sideways between $3.93 and $4.41 over 14 days (Sideways scanner)
Oct 14, 2026: Hit a new 2-Week High of $4.41 (New Highs/Lows scanner)
Oct 7, 2026: News catalyst: Biotech (News Catalysts scanner)
Aug 24, 2026: Spiked to $7.06 on 8M+ shares (Spikes scanner)

ZURA news

Oct 7, 2026: This biotech stock is a top pick at Guggenheim
Sep 11, 2026: Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply
Aug 31, 2026: Zura Bio to Participate in the Cantor Global Healthcare Conference
Aug 21, 2026: Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 11, 2026: Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

About Zura Bio Limited

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Find more stocks like ZURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.